Galip Gürel, DDS, MSc, is the founder and honorary president of the Turkish Academy of Aesthetic Dentistry, a past president of the European Academy of Esthetic Dentistry, and a visiting professor at the New York University, Marseille Dental University, and Istanbul Yeditepe University. He received the 2014 Smigel Prize, which is granted biennially by New York University College of Dentistry to honor the best esthetic dentists in the world. Dr Gürel is the author of The Science and Art of Porcelain Laminate Veneers (Quintessence Publishing, 2003), which has been translated into 12 different languages. He is the editor-in-chief of Quintessence Magazine in Turkey and serves on the editorial boards for several journals.

1983—1989: Studies of Dentistry at RWTH Aachen University Medical and Dental Faculty. 1988—1992: Doctoral Thesis at RWTH Aachen University, Department of Operative Dentistry and Periodontology. 1990—1998: Assoc. Professor. 1992—1995: Master Degree of "Nd-YAG-Laser in Dentistry" at UCSF (University California San Fransisco), USA. Since 2003: Full Professor at RWTH Aachen University. Since 2004: Scientific Director of the Postgraduate Master of Science MSc. course "Lasers in Dentistry". Since 2005: Assoc. Editor in "Journal of Lasers in Medical Science", Springer, London UK. 2005—2015: President DGL German Society for Laser Dentistry. 2008—2010: President World Federation for Laser Dentistry. Since 2010: CEO Chief Executive Officer World Federation for Laser Dentistry WFLD. Since 2012: President of Honor of the World Federation for Laser Dentistry.

Chad Gwaltney, Ph.D. is President and Principal Consultant at Gwaltney Consulting. Dr. Gwaltney develops innovative methods to measure patient-centered outcomes in clinical trials. His academic and industry research includes the design of electronic platforms for the collection of information in real-time in the patient’s natural environment. He has published numerous articles and book chapters addressing how the patient’s perspective can be examined to better understand medical product efficacy and safety. He has served on US National Institutes of Health review committees and has co-authored ISPOR best practice guidelines on the development and use of patient-reported outcomes. Prior to founding Gwaltney Consulting, Dr. Gwaltney was Chief Scientist and Regulatory Advisor, Endpoints, at ERT. Dr. Gwaltney has also served as Head, Patient Experience, Hematology/Oncology, at Celgene and as a research faculty member in the Brown University School of Public Health.